On this episode, Greg Horne interviews Craig Lipset, advisor, advocate and educator in the area of decentralized clinical trials and the former head of clinical innovation at Pfizer. During his time at Pfizer, Craig helped design and lead the first fully remote, decentralized trial. Surprisingly, that was more than a decade ago. Craig explains that the methods, investment and regulatory readiness around decentralized clinical trials has long existed in the industry. The pandemic-related disruptions of early 2020 drove meaningful adoption.